Press: 02 Jan 2006
EUGeneHeart - European Excellence project for heart research
European Union promotes with 11,4 million Euros - coordination in Göttingen.
The biggest heart research project ever promoted by the European Union started its job in January 2006. The EUGeneHeart titled project will be lead by Prof. Dr. Gerd Hasenfuß, managing director of the department of Cardiology and Pneumology and also leader of the Heart Centre of the University of Göttingen.
In EUGeneHeart scientists from 20 institutions located in 10 countries are searching in common for reasons and possibilities for a better treatment of heart failure. The “integrated project” will be supported with a sum of 11,4 million Euros for a period of 5 years.
Heart failure is one of the most frequent diseases and in Europe at about 4 millions of humans are affected. The patients are suffering from limited ability to cope with physical stress and lack on air, there may be a clear reduced lifespan. Heart attack, high blood pressure and valvular defect are main reasons for heart failure. Out of that reason abnormal changes of heart will lead to heart failure.
Aim of this research project is to find out the molecular mechanism leading to these changes and to develop new treatments. This network research will be supported by three innovative industrial enterprises. “We expect by this project new findings for prevention of heart failure and the improved treatment on our patients suffering on heart failure”, says Prof. Dr. Hasenfuss, coordinator of the project. Another aim of the project is the expert training of young physicians in heart research.
The administration of the EU-Liaison Office of Human Medicine of the University will be directed by Christiane Hennecke. The opening of the symposium will take place on January, 13th and 14th in Klinikum of the University of Göttingen under cooperation of the European Commission.
In EUGeneHeart scientists from 20 institutions located in 10 countries are searching in common for reasons and possibilities for a better treatment of heart failure. The “integrated project” will be supported with a sum of 11,4 million Euros for a period of 5 years.
Heart failure is one of the most frequent diseases and in Europe at about 4 millions of humans are affected. The patients are suffering from limited ability to cope with physical stress and lack on air, there may be a clear reduced lifespan. Heart attack, high blood pressure and valvular defect are main reasons for heart failure. Out of that reason abnormal changes of heart will lead to heart failure.
Aim of this research project is to find out the molecular mechanism leading to these changes and to develop new treatments. This network research will be supported by three innovative industrial enterprises. “We expect by this project new findings for prevention of heart failure and the improved treatment on our patients suffering on heart failure”, says Prof. Dr. Hasenfuss, coordinator of the project. Another aim of the project is the expert training of young physicians in heart research.
The administration of the EU-Liaison Office of Human Medicine of the University will be directed by Christiane Hennecke. The opening of the symposium will take place on January, 13th and 14th in Klinikum of the University of Göttingen under cooperation of the European Commission.
Further information:
Prof. Dr. Gerd Hasenfuß,
Coordinator EUGeneHeart
Dept. Cardiology and Pneumology/ Heart Center
Human Medicine – University of Göttingen
mail: administrative.manager@med.uni-goettingen.de
